Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries PerkinElmer (NY: PKI ) 115.24 UNCHANGED Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about PerkinElmer < Previous 1 2 3 Next > Revvity Announces Financial Results for the First Quarter of 2023 May 11, 2023 From Revvity, Inc. Via Business Wire Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure May 09, 2023 From Revvity, Inc. Via Business Wire PerkinElmer Board Declares Quarterly Dividend April 25, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023 April 12, 2023 From PerkinElmer Inc. Via Business Wire PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses March 13, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum March 09, 2023 From PerkinElmer Inc. Via Business Wire PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows February 24, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer to Present at Upcoming Investor Conferences February 22, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022 February 14, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer Board Declares Quarterly Dividend January 26, 2023 From PerkinElmer, Inc. Via Business Wire PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook January 09, 2023 From PerkinElmer Inc. Via Business Wire PerkinElmer to Present at J.P. Morgan Healthcare Conference December 19, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays November 21, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns November 14, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer to Present at 2022 Stifel Healthcare Conference November 10, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer Announces Financial Results for the Third Quarter of 2022 November 08, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report November 07, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer Board Declares Quarterly Dividend October 26, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook October 17, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana October 13, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing September 26, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection September 22, 2022 From PerkinElmer Via Business Wire PerkinElmer to Present at Upcoming Investor Conferences August 24, 2022 From PerkinElmer Inc. Via Business Wire PerkinElmer Announces Finance Leadership Transition August 17, 2022 From PerkinElmer, Inc. Via Business Wire New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion August 01, 2022 From New Mountain Capital Via Business Wire PerkinElmer Announces Financial Results for the Second Quarter of 2022 August 01, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company August 01, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Board Declares Quarterly Dividend July 22, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors July 22, 2022 From PerkinElmer, Inc. Via Business Wire PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022 July 14, 2022 From PerkinElmer, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.